We demonstrated that, in contrast to classical opioid receptors, ACKR3 isn't going to trigger classical G protein signaling and is not modulated by the classical prescription or analgesic opioids, for example morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists including naloxone. Rather, we proven that LIH383, an ACKR3-selective https://richardr493mki0.yourkwikimage.com/user